PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
Conditions: Limited-stage Small-cell Lung Cancer Interventions: Drug: Tislelizumab; Drug: Carboplatin injection; Drug: Cisplatin injection; Drug: Etoposide injection Sponsors: Beijing Chest Hospital, Capital Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Hospitals | Lung Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Small Cell Lung Cancer